Abatacept for the treatment of myositis-associated interstitial lung disease (ATtackMy-ILD)

By sjmartinez • April 25, 2025

Aggarwal R, Pongtarakulpanit N, Sullivan DI, Moghadam-Kia S, Bae SS, Wilkerson J, Saygin D, Marder G, Venuturupalli S, Dellaripa PF, Danoff SK, Doyle T, Hunninghake GM, Lee JS, Fischer A, Falk J, Johnson C, Koontz D, Ascherman DP, Oddis CV. Abatacept for the treatment of myositis-associated interstitial lung disease (ATtackMy-ILD). Rheumatology (Oxford). 2025 Apr 24:keaf218. doi: 10.1093/rheumatology/keaf218. Epub ahead of print. PMID: 40272902.

Tags: abatacept, anti-synthetase syndrome, Cedars Sinai DoM, Idiopathic inflammatory myopathy, interstitial lung disease, placebo-controlled trial, Publications, Pulmonary, Critical Care & Sleep Medicine, randomized, Rheumatology

Quantifying myocardial oxygen consumption and efficiency with motion-resolved cardiac MRI

Huang LT, Yang CC, Wang G, Zhang H, Zhang R, Ho H, Malagi A, Huang Y, Li X, Yoosefian G, Zhang X, Long Z, Bi[...]

On Mentoring

Weisman MH. On Mentoring. Arthritis Care Res (Hoboken). 2026 Mar 23. doi: 10.1002/acr.80045. Epub ahead of print. PMID: 41869975.

The Impact of Transitioning to Virtual Fall-Prevention Programs on Falls and Social Connectedness in Community-Dwelling Older Adults

Mays AM, Au T, Kim S, Guevara N, Rosen SL. The Impact of Transitioning to Virtual Fall-Prevention Programs on Falls and Social Connectedness in Community-Dwelling[...]